NEU 2.37% $19.39 neuren pharmaceuticals limited

Acadia, page-631

  1. 2,818 Posts.
    lightbulb Created with Sketch. 538
    Below are just a few items that may be of interest in relation to Acadia:
    *In addition to the United States Acadia has operations in Denmark-Switzerland-and the UK.
    *The next earnings report is due on the 7/8/2024 as calculated by some algo based on previous years reporting dates.
    *There are 33 hedge funds [including Baker Bros] on the Acadia share register.
    *Acadia debt to equity ratio[debt to net assets] is 12.5% which suits Halal style investors.
    *Typically Acadia cost of goods sold plus research and development costs have been exceeded by sales and administration costs.The total of the above costs has consistently exceeded revenue generation resulting in net profit losses- even though the gross profit margin is around a healthy 10% of sales.In the full financial year 2023 this loss was $61.3M.
    *US style analysts seem to focus their attention solely on earnings generation and completely ignore the net profit issue.
    *The Acadia share price range for the past twelve months has been between $14.65 and $33.99.The Acadia share price closed up 51c at $16.10 last Friday.
    *US analyst revenue estimates for the up coming earnings report look favourable for Acadia and therefore Neuren.
    Kens
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.39
Change
-0.470(2.37%)
Mkt cap ! $2.478B
Open High Low Value Volume
$19.70 $19.77 $19.28 $10.38M 534.0K

Buyers (Bids)

No. Vol. Price($)
3 2680 $19.35
 

Sellers (Offers)

Price($) Vol. No.
$19.41 362 1
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.